Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.
2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
3.

Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).

Vieta E, Herraiz M, Fernández A, Gastó C, Benabarre A, Colom F, Martínez-Arán A, Reinares M.

J Clin Psychiatry. 2001 Aug;62(8):623-30.

PMID:
11561935
4.

Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.

Ciapparelli A, Dell'Osso L, Bandettini di Poggio A, Carmassi C, Cecconi D, Fenzi M, Chiavacci MC, Bottai M, Ramacciotti CE, Cassano GB.

J Clin Psychiatry. 2003 Apr;64(4):451-8.

PMID:
12716249
5.

Clozapine for treatment-refractory mania.

Calabrese JR, Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA, Meltzer HY.

Am J Psychiatry. 1996 Jun;153(6):759-64.

PMID:
8633686
6.

Quetiapine alone and added to a mood stabilizer for serious mood disorders.

Sajatovic M, Brescan DW, Perez DE, DiGiovanni SK, Hattab H, Ray JB, Bingham CR.

J Clin Psychiatry. 2001 Sep;62(9):728-32.

PMID:
11681770
7.

Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.

Kulkarni J, Filia S, Berk L, Filia K, Dodd S, de Castella A, Brnabic AJ, Lowry AJ, Kelin K, Montgomery W, Fitzgerald PB, Berk M.

BMC Psychiatry. 2012 Dec 17;12:228. doi: 10.1186/1471-244X-12-228.

8.

Clozapine in the treatment of refractory psychotic mania.

Green AI, Tohen M, Patel JK, Banov M, DuRand C, Berman I, Chang H, Zarate C Jr, Posener J, Lee H, Dawson R, Richards C, Cole JO, Schatzberg AF.

Am J Psychiatry. 2000 Jun;157(6):982-6.

PMID:
10831480
9.

Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study.

Ciapparelli A, Dell'Osso L, Pini S, Chiavacci MC, Fenzi M, Cassano GB.

J Clin Psychiatry. 2000 May;61(5):329-34.

PMID:
10847306
10.

Low doses of clozapine may stabilize treatment-resistant bipolar patients.

Fehr BS, Ozcan ME, Suppes T.

Eur Arch Psychiatry Clin Neurosci. 2005 Feb;255(1):10-4. Epub 2004 Nov 12.

PMID:
15538596
11.

Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.

Narendran R, Young CM, Valenti AM, Pristach CA, Pato MT, Grace JJ.

J Clin Psychiatry. 2001 Jul;62(7):509-16.

PMID:
11488360
12.

Effects of clozapine on sleep in bipolar and schizoaffective disorders.

Armitage R, Cole D, Suppes T, Ozcan ME.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Nov;28(7):1065-70.

PMID:
15610918
13.

Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders. A case series.

Hummel B, Dittmann S, Forsthoff A, Matzner N, Amann B, Grunze H.

Neuropsychobiology. 2002;45 Suppl 1:37-42.

PMID:
11893876
14.

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.

Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL.

Am J Psychiatry. 2005 Jul;162(7):1281-90.

PMID:
15994710
15.

A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.

Meltzer HY, Bobo WV, Roy A, Jayathilake K, Chen Y, Ertugrul A, Anil Yağcioğlu AE, Small JG.

J Clin Psychiatry. 2008 Feb;69(2):274-85.

PMID:
18232726
16.

Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.

Vieta E, Goikolea JM, Corbella B, Benabarre A, Reinares M, Martínez G, Fernández A, Colom F, Martínez-Arán A, Torrent C; Group for the Study of Risperidone in Affective Disorders (GSRAD).

J Clin Psychiatry. 2001 Oct;62(10):818-25. Erratum in: J Clin Psychiatry 2002 Jan;63(1):79.

PMID:
11816872
17.

A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.

Guille C, Sachs GS, Ghaemi SN.

J Clin Psychiatry. 2000 Sep;61(9):638-42.

PMID:
11030483
18.

The Bipolar Comprehensive Outcomes Study (BCOS): baseline findings of an Australian cohort study.

Kulkarni J, Berk M, Fitzgerald PB, de Castella AR, Montgomery W, Kelin K, Brnabic A, Granger RE, Dodd S.

J Affect Disord. 2008 Apr;107(1-3):135-44. Epub 2007 Sep 24.

PMID:
17889373
19.

Response to clozapine of rapid cycling versus non-cycling patients with a history of mania.

Suppes T, Ozcan ME, Carmody T.

Bipolar Disord. 2004 Aug;6(4):329-32.

PMID:
15225152
20.

Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: results of an open-label study.

Cabras PL, Hardoy MJ, Hardoy MC, Carta MG.

J Clin Psychiatry. 1999 Apr;60(4):245-8.

PMID:
10221286
Items per page

Supplemental Content

Write to the Help Desk